Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 15/12/22 → 14/12/27 |
A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Inflammatory Bowel Disease
- Moore, Gregory (Primary Chief Investigator (PCI))
Project: Research